Valiant Navion™ VNMF4343C223TU (UDI 00763000100773)Recalls & reported problems
Medtronic, Inc. · STENT GRAFT VNMF4343C223TU VAL NAV FF · Class 3 · Implant
All models of Valiant Navion (137)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 3
- Deaths reported
- 1
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 00763000100773), received between Jul 15, 2022 and Apr 1, 2025 — classified as 1 death, 1 injury, 1 malfunction.
The most frequently reported specific device problem is “Detachment of Device or Device Component” (2 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Detachment of Device or Device Component2
- Leak/Splash2
Patient problems
- No Clinical Signs, Symptoms or Conditions2
- Aneurysm expansion1
- Rupture1
Recent adverse event reports
The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.
InjuryApr 1, 2025Leak/Splash; Detachment of Device or Device Component; Leak/Splash; Detachment of Device or Device Component
VALIANT NAVION STENT GRAFTS WERE IMPLANTED DURING THE ENDOVASCULAR TREATMENT OF A THORACIC AORTIC ANEURYSM. IT WAS REPORTED CORE LAB REVIEW OF CT IMAGING FROM APPROX. 48 MONTHS POST INDEX PROCEDURE, NOTED A NEW STENT RING ENLARGEMENT OF + 1.5MM WAS NOTED ON RING 4 OF (B)(6) AND +1.6MM ON RING 6 OF (B)(6). A NEW TYPE IIIB ENDOLEAK OBSERVED ON STENT GRAFT (B)(6). NO FRACTURE OR STENT RING MIGRATION WERE NOTED. THE MAXIMUM AORTIC DIAMETER MEASURED 58.5MM. NO AORTIC ENLARGEMENT WAS REPORTED. NO STENT RING MIGRATION OR STENT FRACTURES WERE OBSERVED. NO ADDITIONAL CLINICAL SEQUELAE WERE PROVIDED AND THE PATIENT WILL BE MONITORED.
Patient problems: Aneurysm expansion; No Clinical Signs, Symptoms or Conditions
MAUDE report 21738586 ↗MalfunctionFeb 9, 2024Detachment of Device or Device Component; Detachment of Device or Device Component
TWO VALIANT NAVION STENT GRAFTS WERE IMPLANTED DURING THE ENDOVASCULAR TREATMENT OF A TYPE B AORTIC DISSECTION. THE PATIENT ALSO HAD A VALIANT CAPTIVIA AND NON MDT GRAFT IMPLANTED 2 YEARS POST THE INDEX PROCEDURE. IT WAS REPORTED CORE LAB REVIEW CT IMAGING FROM APPROXIMATELY 4 YEARS POST THE INDEX PROCEDURE SHOWED NEW STENT RING ENLARGEMENT OF +1.6MM, ON RING 3 OF VNMF4343C223TU. NO ENDOLEAK, STENT FRACTURE OR STENT RING MIGRATION WAS OBSERVED. THE MAX AORTIC DIAMETER WAS NOTED AS 53.5MM. NO AORTIC ENLARGEMENT WAS OBSERVED. THE CAUSE OF THE STENT RING ENLARGEMENT IS UNDETERMINED. NO ADDITIONAL SEQUELAE WERE REPORTED AND THE PATIENTS WILL BE MONITORED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 18675430 ↗DeathJul 15, 2022Leak/Splash; Leak/Splash
VALIANT NAVION STENT GRAFTS WERE IMPLANTED FOR THE ENDOVASCULAR TREATMENT OF A 100MM THORACIC AORTIC ANEURYSM. ANOTHER VALIANT NAVION STENT GRAFT WAS IMPLANTED THE NEXT DAY. IT WAS REPORTED THE PATIENT PRESENTED EMERGENTLY APPROXIMATELY 11 MONTHS POST INDEX PROCEDURE WITH A THORACIC RUPTURE. THE PHYSICIAN STATED THE CT SHOWED A POSSIBLE TYPE III ENDOLEAK. THE PATIENT EXPIRED ON THE SAME DAY. AS PER THE PHYSICIAN THE CAUSE OF DEATH WAS AS A RESULT OF THE THORACIC RUPTURE. NO CAUSE OF THE ENDOLEAK HAS BEEN REPORTED. NO ADDITIONAL CLINICAL SEQUALAE WAS PROVIDED AND THE PATIENT HAS EXPIRED.
Patient problems: Rupture
MAUDE report 15026139 ↗
Other SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT devices
- Endurant® IIs ESBF2814C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls34 deaths254 reports
- Endurant® IIs ESBF3214C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls19 deaths173 reports
- Endurant® IIs ESBF3614C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT1 recall37 deaths214 reports
- Endurant® IIs ESBF2514C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls18 deaths136 reports
- Endurant® IIs ESBF2314C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls9 deaths60 reports
- RelayPro Thoracic Stent-Graft System 28-N4-34-154-34UBolton Medical Inc. · System, Endovascular Graft, Aortic Aneurysm Treatment3 recalls7 reports
- Vela Proximal Endograft System A34-34/C100-O20 VEndologix LLC · System, Endovascular Graft, Aortic Aneurysm Treatment3 deaths152 reports
- Endurant® II ETCF2828C49EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls7 deaths44 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page